ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

Recruiting now

Conditions studied: Sepsis, Septic Shock, Immunoparalysis in Septic Shock

In brief

The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.

Key facts

Study ID

NCT07388628

Run by

Artcline GmbH

People needed

200

Starts

2025-09-25

Expected to finish

2027-12-01

Last updated by the study team

2026-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay

Where it is running

• Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin — Magdeburg, Germany (enrolling)
• Johannes Wesling Klinikum, Universitätsklinik für Anästhesiologie, Intensiv & Notfallmedizin — Minden, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.